The Centers for Disease Control and Prevention stated on Thursday that people are advised to not get the Johnson & Johnson Covid-19 vaccine when the Pfizer-BioNTech and Moderna shots are accessible, The suggestion, from CDC Director Dr. Rochelle Walensky, came hours after partners of the agency’s Advisory Committee on Immunization Practices chose in favor of the recommendation. The committee assembled after an update from the Food and Drug Administration on the danger of rare but life-threatening blood clots associated with the Johnson & Johnson vaccine. Around 54 individuals in the U.S., mostly women, have been hospitalized by the blood clots, and nine people have died. Walensky stated that today’s new proposal intensifies CDC’s responsibility to deliver real-time scientific data to the American people. He continues to encourage all Americans to get vaccinated and boost.
The advisory committee picked unanimously to declare the mRNA vaccines, from Pfizer and Moderna, the preferred alternatives for adults, eventually inferring that the mRNA vaccines delivered vast protection and limited risks than Johnson & Johnson’s. The suggestion wouldn’t restrict the usage of the Johnson & Johnson shot but rather make it visible that the other alternatives are better options if they are accessible really cannot propose a vaccine that has been linked with a condition that may lead to death asserted a committee partner, Dr. Pablo Sanchez who is a pediatrician at Nationwide Children’s Hospital in Ohio. Johnson & Johnson’s vaccine is associated with a blood clotting condition known as thrombosis with thrombocytopenia syndrome, or TTS. The AstraZeneca vaccine has also been associated with the blood clot problem. Both the Johnson & Johnson and the AstraZeneca vaccines utilize adenovirus technology to equip the immune system to combat the coronavirus. The shots formulated by Pfizer-BioNTech and Moderna utilize a distinct approach, mRNA, to equip the immune system, and they haven’t been associated with the clots.
